Share this article ... Acceleron Fusion, a pioneer in muon-catalyzed fusion energy, has closed a $24 million Series A funding round. The funding...
7 months ago

Acceleron Fusion is the latest startup to take a swing at this challenging nuclear-energy technology, banking on a novel approach that uses...
7 months ago

Acceleron says the funding will support efforts to advance its low-temperature muon-catalysed fusion technology – sometimes described as a form of cold fusion.
6 months ago

A young startup, Acceleron Fusion, is joining the pack, having raised $15 million of a targeted $23.7 million round, according to an SEC filing.
9 months ago

Managed Services is helping Accelleron build a future-fit operating model. Read more in this case study.
5 months ago

Eight months after snaring an inaugural FDA green light, Merck & Co. is bolstering the case for the chief asset in its $11.5 billion...
7 months ago

With pre-integration into Payments Exchange from Fiserv, banks and credit unions can easily leverage Acceleron's competitive pricing without the...
8 months ago

The approval is the latest milestone in sotatercept's comeback story. Mid-stage results in early 2020 sparked a “successful resurrection” of the...
3 months ago

Merck to buy Acceleron for about $11.5 billion in rare-disease drugs push ... Merck is buying Acceleron Pharma for about $11.5 billion, broadening...
45 months ago

Merck & Co. announced Thursday it has agreed to buy Acceleron Pharma for $11.5 billion. If completed, the deal would be the largest biopharma...
45 months ago